Top Markets
Coin of the day
Q32 Bio Inc. Q32 Bio Inc.

Q32 Bio Inc.

QTTB
Pozycja w akcjach #14023
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to... Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders stemming from dysfunctional immune responses. The company's primary investigational therapy, ADX-097, is a humanized anti-C3d monoclonal antibody fusion protein designed to normalize complement regulation. This candidate has successfully finished its Phase I clinical trial, targeting severe renal and other complement-driven conditions where patient needs are largely unmet, such as lupus nephritis, IgA nephropathy, C3 glomerulopathy, and ANCA-associated vasculitis. Additionally, Q32 Bio is advancing Bempikibart (ADX-914), a fully human monoclonal antibody antagonist against interleukin-7 receptor alpha. Currently in Phase II trials, Bempikibart aims to recalibrate adaptive immune responses by inhibiting signaling pathways involving interleukin-7 and thymic stromal lymphopoietin, offering potential treatment for atopic dermatitis and alopecia areata. Founded in 2017 and headquartered in Waltham, Massachusetts, Q32 Bio Inc. adopted its current name in April 2020, having previously operated as AdMIRx Inc.
Cena akcji
$14.86
Ostatnia synchronizacja: 2026-08-31
Kapitalizacja rynkowa
$442.29M
Zmiana (1 dzień)
-1.13%
Zmiana (1 rok)
769.01%
Kraj
US
Handel Q32 Bio Inc. (QTTB)

Kategoria

Historia ceny akcji dla Q32 Bio Inc. (QTTB)
Najwyższa cena zamknięcia: $15.70 dnia 2026-08-01

Najniższa cena zamknięcia: $336.24 dnia 2018-03-01
Historia cen akcji firmy Q32 Bio Inc. od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 104.51%
2025 -69.67%
2024 6.01%
2023 -59.20%
2022 -67.95%
2021 -61.63%
2020 -44.79%
2019 -12.56%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$544.38 39.22%
US
$1.03K 45.21%
NL
$122.88 -10.84%
AU
$138.80 476.17%
US
$749.90 5.10%
CH